Standout Papers
Immediate Impact
2 from Science/Nature 56 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of S Goddu being referenced
Radioprotection by Dmso Against the Biological Effects of Incorporated Radionuclides in Vivo: Comparison with other radioprotectors and evidence for indirect action of Auger electrons
1996
Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides.
1994
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| S Goddu | 1180 | 1383 | 898 | 97 | 2.1k | |
| Judit Boda‐Heggemann | 1312 | 1034 | 878 | 94 | 1.8k | |
| Raphaël Moeckli | 1950 | 1044 | 1981 | 118 | 2.8k | |
| Lisanne V. van Dijk | 645 | 1206 | 621 | 87 | 1.8k | |
| Laura Cella | 1088 | 943 | 1046 | 90 | 2.1k | |
| Rojano Kashani | 1768 | 1606 | 1136 | 74 | 2.5k | |
| Tom R. Miller | 522 | 1418 | 737 | 48 | 2.3k | |
| Panayiotis Mavroidis | 1372 | 1063 | 1377 | 178 | 2.3k | |
| Peter van Luijk | 1044 | 1228 | 1420 | 72 | 2.8k | |
| Oliver Blanck | 1182 | 976 | 1143 | 129 | 2.3k | |
| A. Bruynzeel | 1254 | 1047 | 1190 | 76 | 2.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...